Analysts Set Bio-Techne Co. (NASDAQ:TECH) PT at $86.57
Bio-Techne Co. (NASDAQ:TECH – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven research firms that are covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month price objective among […]
Bio-Techne Co. (NASDAQ:TECH – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven research firms that are covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month price objective among […]
